Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
AMG 133 (now known as maridebart cafraglutide) is an optimized GIPR/GLP-1R bispecific molecule engineered by conjugating a fully human monoclonal anti-human GIPR-Ab with two GLP-1 analogue agonist peptides using amino acid linkers
In recent years, it has gained attention for its potential benefits in weight management
7 Figure
However, multinational pharmaceutical companies have already begun building localized production and supply networks in anticipation of future demand
US$ 27.03
US$ 20.89
US$ 22.83
